Themis Bioscience  Vaccines to prevent infectious diseases

MSD (Merck & Co., Inc.) acquired Themis

Themis Bioscience developed vaccines to prevent infectious diseases and combat cancer. Themis’ vaccine technology is based on science from the renowned vaccine research center at Institute Pasteur in Paris.

Industry

Therapeutics

Case facts

Location

Austria

Status

Exit June 2020

Involved Team